Aquarius Surgical Technologies released its earnings results on Nov 28, 2024. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.

Q: Is Aquarius Surgical Technologies overvalued?

According to Wall Street analysts Aquarius Surgical Technologies ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Aquarius Surgical Technologies have?

Aquarius Surgical Technologies has 27,599,173 shares outstanding.

Q: What happened to Aquarius Surgical Technologies ’s price movement after its last earnings report?

Aquarius Surgical Technologies reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Compare

7 Followers

AQQRF Stock Chart & Stats

Day’s Range― - ―

52-Week Range<$0.01 - $1.00

Previous CloseN/A

Volume1.00

Average Volume (3M)0.00

Market Cap

$387.72K

Enterprise Value$1.01M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.40

Next Earnings

Mar 04, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding27,599,173

10 Day Avg. Volume0

30 Day Avg. Volume0

Standard Deviation0.95

R-Squared0.14

Alpha0.32

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)3.61

Price to Cash Flow (P/CF)-1.40

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Financials

Quarterly

Income Statement >

AQQRF FAQ

What was Aquarius Surgical Technologies ’s price range in the past 12 months?

Aquarius Surgical Technologies lowest stock price was <$0.01 and its highest was $1.00 in the past 12 months.

What is Aquarius Surgical Technologies ’s market cap?

Aquarius Surgical Technologies ’s market cap is $387.72K.

When is Aquarius Surgical Technologies ’s upcoming earnings report date?

Aquarius Surgical Technologies ’s upcoming earnings report date is Mar 04, 2025 which is in 9 days.

How were Aquarius Surgical Technologies ’s earnings last quarter?

Aquarius Surgical Technologies released its earnings results on Nov 28, 2024. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.

Is Aquarius Surgical Technologies overvalued?

According to Wall Street analysts Aquarius Surgical Technologies ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies pay dividends?

Aquarius Surgical Technologies does not currently pay dividends.

What is Aquarius Surgical Technologies ’s EPS estimate?

Aquarius Surgical Technologies ’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies have?

Aquarius Surgical Technologies has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies ’s price movement after its last earnings report?

Aquarius Surgical Technologies reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aquarius Surgical Technologies ?

Currently, no hedge funds are holding shares in AQQRF

---

Company Description

Aquarius Surgical Technologies

Aquarius Surgical Technologies, Inc. engages in the provision of innovative, minimally invasive medical laser systems, and consumables for multiple medical disciplines, principally in the field of urology. It offer multiple laser systems, consumables, clinical education, service, support, and maintenance solutions. The company was founded on December 12, 1986 and is headquartered in Halifax, Canada.

---

Similar Stocks

NAK

Northern Dynasty Minerals

―

KHTRF

Knight Therapeutics

―

THCBF

THC Biomed INTL

―

MFCSF